IPI Legacy Liquidation Co's quarterly market cap
declined
from Mar. 2023 ($33.24 Mil) to Jun. 2023 ($30.16 Mil) and
declined
from Jun. 2023 ($30.16 Mil) to Sep. 2023 ($10.21 Mil).
IPI Legacy Liquidation Co's annual market cap
increased
from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($199.55 Mil) but then
declined
from Dec. 2021 ($199.55 Mil) to Dec. 2022 ($89.02 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. IPI Legacy Liquidation Co's Enterprise Value for Today is $114.92 Mil.
IPI Legacy Liquidation Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of IPI Legacy Liquidation Co's Market Cap
For the Biotechnology subindustry, IPI Legacy Liquidation Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IPI Legacy Liquidation Co's Market Cap Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, IPI Legacy Liquidation Co's Market Cap distribution charts can be found below:
* The bar in red indicates where IPI Legacy Liquidation Co's Market Cap falls into.
IPI Legacy Liquidation Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
IPI Legacy Liquidation Co (OTCPK:IMPLQ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
IPI Legacy Liquidation Co Market Cap Related Terms
Thank you for viewing the detailed overview of IPI Legacy Liquidation Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
IPI Legacy Liquidation Co (IPI Legacy Liquidation Co) Business Description
Impel Pharmaceuticals Inc is a commercial-stage pharmaceutical company focused on utilizing its proprietary technology to develop and commercialize transformative therapies for patients suffering from diseases with high unmet medical needs, with an initial focus on diseases of the central nervous system. The company is developing an approach to drug delivery that administers specific formulations of drugs deep into the vascular-rich upper nasal space, a gateway for therapeutic administration of a versatile range of molecules and formulations.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IMPLQ has been successfully added to your 